Ingevity (NGVT)
Ingevity on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on NYSE, classified by the SEC as chemicals & allied products.
1.5M
Short interest
settlement 2026-09-30
4.8
Days to cover
-1.3 days vs prior
58.1%
Short share of volume
2026-10-23
287
Fails to deliver
settlement 2026-09-23
Wed 4 Nov
Next earnings
estimated date
-$1.7M
Insider flow, 90 days
0 buys, 7 sells
As of 2026-10-23.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in NGVT is 1,456,145 shares, up 139,576 shares over the last month. Over the last 48 readings it ranged from 744,362 shares (29 August 2025) to 1,476,017 shares (15 December 2025). The latest reading sits at the top of that range. At the reported average volume of 306K shares a day that is 4.8 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/ngvt" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 1,456,145 | +0.8% | 305,631 | 4.76 |
| 2026-09-15 | 1,443,989 | +9.7% | 237,019 | 6.09 |
| 2026-08-31 | 1,316,569 | +5.2% | 214,097 | 6.15 |
| 2026-08-14 | 1,251,332 | +1.4% | 248,089 | 5.04 |
| 2026-07-31 | 1,234,603 | +3.0% | 248,890 | 4.96 |
| 2026-07-15 | 1,198,437 | +4.8% | 220,623 | 5.43 |
| 2026-06-30 | 1,143,916 | +4.9% | 416,704 | 2.75 |
| 2026-06-15 | 1,090,837 | +15.8% | 234,471 | 4.65 |
| 2026-05-29 | 941,986 | -8.6% | 220,073 | 4.28 |
| 2026-05-15 | 1,030,856 | -7.7% | 275,896 | 3.74 |
| 2026-04-30 | 1,116,427 | -3.0% | 212,180 | 5.26 |
| 2026-04-15 | 1,151,073 | -7.8% | 233,399 | 4.93 |
| 2026-03-31 | 1,248,887 | -2.8% | 395,768 | 3.16 |
| 2026-03-13 | 1,284,483 | -1.4% | 404,953 | 3.17 |
| 2026-02-27 | 1,302,815 | -0.5% | 406,861 | 3.20 |
| 2026-02-13 | 1,309,376 | -6.1% | 308,385 | 4.25 |
| 2026-01-30 | 1,394,695 | -2.2% | 319,771 | 4.36 |
| 2026-01-15 | 1,426,542 | +2.4% | 252,453 | 5.65 |
| 2025-12-31 | 1,392,783 | -5.6% | 315,493 | 4.41 |
| 2025-12-15 | 1,476,017 | +27.2% | 363,860 | 4.06 |
| 2025-11-28 | 1,160,021 | +14.2% | 275,269 | 4.21 |
| 2025-11-14 | 1,015,925 | +16.6% | 389,581 | 2.61 |
| 2025-10-31 | 871,370 | -6.3% | 164,427 | 5.30 |
| 2025-10-15 | 929,966 | +0.3% | 195,507 | 4.76 |
| 2025-09-30 | 927,620 | +12.0% | 244,734 | 3.79 |
| 2025-09-15 | 828,233 | +11.3% | 233,671 | 3.54 |
| 2025-08-29 | 744,362 | -23.3% | 278,843 | 2.67 |
| 2025-08-15 | 969,817 | -13.3% | 430,905 | 2.25 |
| 2025-07-31 | 1,118,101 | -7.8% | 194,715 | 5.74 |
| 2025-07-15 | 1,212,246 | +2.1% | 205,042 | 5.91 |
| 2025-06-30 | 1,187,031 | -3.2% | 214,358 | 5.54 |
| 2025-06-13 | 1,225,839 | +7.0% | 196,861 | 6.23 |
| 2025-05-30 | 1,145,265 | -14.9% | 228,604 | 5.01 |
| 2025-05-15 | 1,345,919 | +0.8% | 361,898 | 3.72 |
| 2025-04-30 | 1,335,681 | -3.7% | 242,645 | 5.50 |
| 2025-04-15 | 1,386,391 | +10.2% | 317,849 | 4.36 |
| 2025-03-31 | 1,258,065 | +4.4% | 244,784 | 5.14 |
| 2025-03-14 | 1,205,479 | +4.6% | 300,799 | 4.01 |
| 2025-02-28 | 1,152,779 | +2.9% | 337,681 | 3.41 |
| 2025-02-14 | 1,120,503 | -0.8% | 183,416 | 6.11 |
| 2025-01-31 | 1,130,139 | -1.8% | 199,004 | 5.68 |
| 2025-01-15 | 1,150,964 | -3.8% | 219,707 | 5.24 |
| 2024-12-31 | 1,196,041 | +1.6% | 260,446 | 4.59 |
| 2024-12-13 | 1,177,337 | +11.2% | 219,868 | 5.35 |
| 2024-11-29 | 1,059,247 | -10.3% | 237,144 | 4.47 |
| 2024-11-15 | 1,180,580 | +10.5% | 375,245 | 3.15 |
| 2024-10-31 | 1,068,204 | +1.3% | 388,601 | 2.75 |
| 2024-10-15 | 1,054,805 | +1.5% | 414,756 | 2.54 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 23 October 2026, the short share of NGVT volume is 58.1%, up 9.1 points over the last five sessions. Over the last 30 readings it ranged from 34.9% (17 September 2026) to 79.9% (22 September 2026). The latest reading is in line with the 30-session average of 59.2%, on 78K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-23 | 45K | 78K | 58.1% | 0 |
| 2026-10-22 | 46K | 101K | 45.4% | 0 |
| 2026-10-21 | 45K | 104K | 43.6% | 0 |
| 2026-10-20 | 45K | 108K | 42.0% | 0 |
| 2026-10-19 | 42K | 81K | 51.6% | 0 |
| 2026-10-16 | 26K | 52K | 49.0% | 0 |
| 2026-10-15 | 35K | 55K | 64.0% | 0 |
| 2026-10-14 | 59K | 81K | 72.3% | 0 |
| 2026-10-13 | 33K | 81K | 40.6% | 0 |
| 2026-10-12 | 40K | 95K | 42.2% | 0 |
| 2026-10-09 | 33K | 81K | 40.9% | 0 |
| 2026-10-08 | 46K | 78K | 59.0% | 802 |
| 2026-10-07 | 41K | 73K | 55.9% | 0 |
| 2026-10-06 | 48K | 62K | 78.3% | 0 |
| 2026-10-05 | 53K | 69K | 76.6% | 637 |
| 2026-10-02 | 35K | 65K | 54.5% | 605 |
| 2026-10-01 | 63K | 99K | 63.6% | 0 |
| 2026-09-30 | 93K | 130K | 71.7% | 0 |
| 2026-09-29 | 56K | 108K | 52.0% | 0 |
| 2026-09-28 | 29K | 45K | 64.3% | 0 |
| 2026-09-25 | 50K | 69K | 72.2% | 0 |
| 2026-09-24 | 51K | 65K | 78.3% | 0 |
| 2026-09-23 | 54K | 72K | 75.1% | 0 |
| 2026-09-22 | 70K | 88K | 79.9% | 0 |
| 2026-09-21 | 44K | 85K | 51.8% | 0 |
| 2026-09-18 | 36K | 62K | 59.2% | 0 |
| 2026-09-17 | 36K | 104K | 34.9% | 0 |
| 2026-09-16 | 36K | 56K | 64.7% | 0 |
| 2026-09-15 | 29K | 40K | 72.9% | 0 |
| 2026-09-14 | 54K | 88K | 61.7% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 23 September 2026, the fails-to-deliver balance in NGVT is 287 shares, up 236 shares over the last settlement date. Over the last 30 readings it ranged from 2 shares (26 March 2026) to 7,985 shares (3 March 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-23 | 287 | $71.27 | $20K |
| 2026-09-22 | 51 | $68.96 | $4K |
| 2026-09-16 | 3 | $67.84 | $204 |
| 2026-09-14 | 5,126 | $69.41 | $356K |
| 2026-09-10 | 202 | $68.10 | $14K |
| 2026-09-02 | 1,411 | $68.51 | $97K |
| 2026-08-24 | 215 | $70.27 | $15K |
| 2026-07-31 | 600 | $70.19 | $42K |
| 2026-07-20 | 475 | $76.53 | $36K |
| 2026-07-14 | 309 | $71.60 | $22K |
| 2026-07-01 | 44 | $74.67 | $3K |
| 2026-06-29 | 6,617 | $77.12 | $510K |
| 2026-06-26 | 75 | $74.17 | $6K |
| 2026-06-18 | 813 | $71.75 | $58K |
| 2026-04-02 | 12 | $72.28 | $867 |
| 2026-03-26 | 2 | $71.78 | $144 |
| 2026-03-25 | 519 | $69.50 | $36K |
| 2026-03-24 | 5 | $66.80 | $334 |
| 2026-03-11 | 1,967 | $65.51 | $129K |
| 2026-03-03 | 7,985 | $71.64 | $572K |
| 2026-02-26 | 8 | $69.60 | $557 |
| 2026-02-25 | 11 | $71.12 | $782 |
| 2026-02-19 | 14 | $74.31 | $1K |
| 2026-02-18 | 62 | $75.81 | $5K |
| 2026-02-17 | 8 | $76.57 | $613 |
| 2026-02-09 | 36 | $72.69 | $3K |
| 2026-01-16 | 183 | $66.93 | $12K |
| 2026-01-14 | 3 | $65.80 | $197 |
| 2025-12-23 | 47 | $59.77 | $3K |
| 2025-11-24 | 636 | $49.56 | $32K |
Insider trades
SEC Form 4, newest first. JSONInsiders at NGVT reported 7 open-market sells worth $1.7M in the last 90 days and no open-market buys. Latest filing: WILLIS J KEVIN (Director) on 2026-10-01.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | WILLIS J KEVIN | Director | Grant | 405 | $71.09 | $29K | 12K |
| 2026-10-01 | Segal Francis David | Director | Grant | 335 | $71.09 | $24K | 9K |
| 2026-08-18 | Li David H | President & CEO | Sell | 92 | $74.71 | $7K | 121K |
| 2026-08-17 | Li David H | President & CEO | Sell | 5K | $75.83 | $379K | 121K |
| 2026-08-14 | Li David H | President & CEO | Sell | 5K | $75.73 | $379K | 126K |
| 2026-08-13 | Li David H | President & CEO | Sell | 5K | $75.73 | $379K | 131K |
| 2026-08-12 | Li David H | President & CEO | Sell | 5K | $76.62 | $383K | 136K |
| 2026-08-10 | PLATT PHILLIP JOHN | SVP, Chief Financial Officer | Tax withholding | 2K | $77.04 | $131K | 27K |
| 2026-08-03 | Fisher Ryan C. | SVP, Gen. Counsel & Secretary | Sell | 1K | $73.67 | $97K | 16K |
| 2026-08-03 | Fisher Ryan C. | SVP, Gen. Counsel & Secretary | Sell | 1K | $73.76 | $103K | 17K |
| 2026-07-24 | PLATT PHILLIP JOHN | SVP, Chief Financial Officer | Tax withholding | 3K | $73.26 | $241K | 28K |
| 2026-07-06 | Fisher Ryan C. | SVP, Gen. Counsel & Secretary | Tax withholding | 168 | $73.86 | $12K | 18K |
| 2026-07-01 | Segal Francis David | Director | Grant | 328 | $72.58 | $24K | 9K |
| 2026-07-01 | WILLIS J KEVIN | Director | Grant | 397 | $72.58 | $29K | 11K |
| 2026-06-22 | Cotterman Ryan Joseph | VP, Chief Accounting Officer | Grant | 2K | $0.00 | $0 | 2K |
| 2026-05-28 | DYER TERRANCE M | SVP, Chief HR Officer | Sell | 200 | $68.53 | $14K | 7K |
| 2026-05-28 | DYER TERRANCE M | SVP, Chief HR Officer | Sell | 30 | $68.57 | $2K | 7K |
| 2026-05-28 | DYER TERRANCE M | SVP, Chief HR Officer | Sell | 266 | $68.45 | $18K | 7K |
| 2026-05-01 | PLATT PHILLIP JOHN | SVP, Finance & CAO | Grant | 1K | $0.00 | $0 | 32K |
| 2026-04-30 | Segal Francis David | Director | Grant | 2K | $0.00 | $0 | 8K |
| 2026-04-30 | Wright Benjamin G. | Director | Grant | 2K | $0.00 | $0 | 12K |
| 2026-04-30 | Lynch Frederick J | Director | Grant | 2K | $0.00 | $0 | 28K |
| 2026-04-30 | WILLIS J KEVIN | Director | Grant | 2K | $0.00 | $0 | 11K |
| 2026-04-30 | NARWOLD KAREN G | Director | Grant | 2K | $0.00 | $0 | 19K |
| 2026-04-30 | Hoechner Bruce D. | Director | Grant | 2K | $0.00 | $0 | 11K |
| 2026-04-30 | Gulyas Diane H. | Director | Grant | 2K | $0.00 | $0 | 15K |
| 2026-04-30 | FERNANDEZ-MORENO LUIS M | Director | Grant | 2K | $0.00 | $0 | 38K |
| 2026-04-07 | Li David H | President & CEO | Tax withholding | 4K | $70.57 | $252K | 141K |
| 2026-04-07 | Li David H | President & CEO | Tax withholding | 13K | $70.57 | $925K | 144K |
| 2026-04-01 | Segal Francis David | Director | Grant | 329 | $72.28 | $24K | 6K |
| 2026-04-01 | WILLIS J KEVIN | Director | Grant | 398 | $72.28 | $29K | 9K |
| 2026-03-25 | Fisher Ryan C. | SVP, Gen. Counsel & Secretary | Tax withholding | 308 | $71.78 | $22K | 18K |
| 2026-03-02 | White Richard Allen JR | SVP and Pres, Perf Chemicals | Tax withholding | 755 | $71.64 | $54K | 20K |
| 2026-03-02 | White Richard Allen JR | SVP and Pres, Perf Chemicals | Tax withholding | 217 | $71.64 | $16K | 21K |
| 2026-03-02 | White Richard Allen JR | SVP and Pres, Perf Chemicals | Tax withholding | 617 | $71.64 | $44K | 21K |
| 2026-03-02 | White Richard Allen JR | SVP and Pres, Perf Chemicals | Tax withholding | 351 | $71.64 | $25K | 22K |
| 2026-03-02 | PLATT PHILLIP JOHN | SVP, Finance & CAO | Tax withholding | 340 | $71.64 | $24K | 30K |
| 2026-03-02 | PLATT PHILLIP JOHN | SVP, Finance & CAO | Tax withholding | 99 | $71.64 | $7K | 30K |
| 2026-03-02 | PLATT PHILLIP JOHN | SVP, Finance & CAO | Tax withholding | 407 | $71.64 | $29K | 30K |
| 2026-03-02 | PLATT PHILLIP JOHN | SVP, Finance & CAO | Tax withholding | 224 | $71.64 | $16K | 31K |
| 2026-03-02 | Hall Mary Dean | EVP, Chief Financial Officer | Tax withholding | 2K | $71.64 | $120K | 37K |
| 2026-03-02 | Hall Mary Dean | EVP, Chief Financial Officer | Tax withholding | 559 | $71.64 | $40K | 39K |
| 2026-03-02 | Hall Mary Dean | EVP, Chief Financial Officer | Tax withholding | 1K | $71.64 | $98K | 40K |
| 2026-03-02 | Hall Mary Dean | EVP, Chief Financial Officer | Tax withholding | 747 | $71.64 | $54K | 41K |
| 2026-03-02 | Fisher Ryan C. | SVP, Gen. Counsel & Secretary | Tax withholding | 680 | $71.64 | $49K | 19K |
| 2026-03-02 | Fisher Ryan C. | SVP, Gen. Counsel & Secretary | Tax withholding | 103 | $71.64 | $7K | 19K |
| 2026-03-02 | Fisher Ryan C. | SVP, Gen. Counsel & Secretary | Tax withholding | 355 | $71.64 | $25K | 19K |
| 2026-03-02 | Fisher Ryan C. | SVP, Gen. Counsel & Secretary | Tax withholding | 195 | $71.64 | $14K | 20K |
| 2026-03-02 | DYER TERRANCE M | SVP, Chief HR Officer | Tax withholding | 550 | $71.64 | $39K | 8K |
| 2026-03-02 | Clontz Clarence Reid Jr. | SVP, Operations | Tax withholding | 270 | $71.64 | $19K | 9K |
| 2026-03-02 | Clontz Clarence Reid Jr. | SVP, Operations | Tax withholding | 49 | $71.64 | $4K | 9K |
| 2026-03-02 | Clontz Clarence Reid Jr. | SVP, Operations | Tax withholding | 264 | $71.64 | $19K | 9K |
| 2026-03-02 | Clontz Clarence Reid Jr. | SVP, Operations | Tax withholding | 143 | $71.64 | $10K | 10K |
| 2026-02-27 | Shukov Michael N. | SVP and Pres, APT | Grant | 1K | $0.00 | $0 | 1K |
| 2026-02-27 | PLATT PHILLIP JOHN | SVP, Finance & CAO | Grant | 2K | $0.00 | $0 | 31K |
| 2026-02-27 | Li David H | President & CEO | Grant | 38K | $0.00 | $0 | 157K |
| 2026-02-27 | Fisher Ryan C. | SVP, Gen. Counsel & Secretary | Grant | 4K | $0.00 | $0 | 20K |
| 2026-02-27 | DYER TERRANCE M | SVP, Chief HR Officer | Grant | 4K | $0.00 | $0 | 8K |
| 2026-02-27 | Clontz Clarence Reid Jr. | SVP, Operations | Grant | 2K | $0.00 | $0 | 10K |
| 2026-02-27 | Castillo Ruth | SVP and Pres, Perf Materials | Grant | 4K | $0.00 | $0 | 4K |
| 2026-02-26 | White Richard Allen JR | SVP and Pres, Perf Chemicals | Grant | 430 | $70.52 | $30K | 22K |
| 2026-02-26 | White Richard Allen JR | SVP and Pres, Perf Chemicals | Grant | 1K | $0.00 | $0 | 22K |
| 2026-02-26 | PLATT PHILLIP JOHN | SVP, Finance & CAO | Tax withholding | 108 | $70.52 | $8K | 29K |
| 2026-02-26 | PLATT PHILLIP JOHN | SVP, Finance & CAO | Grant | 247 | $0.00 | $0 | 29K |
| 2026-02-26 | Hall Mary Dean | EVP, Chief Financial Officer | Tax withholding | 873 | $70.52 | $62K | 42K |
| 2026-02-26 | Hall Mary Dean | EVP, Chief Financial Officer | Grant | 2K | $0.00 | $0 | 43K |
| 2026-02-26 | Fisher Ryan C. | SVP, Gen. Counsel & Secretary | Tax withholding | 94 | $70.52 | $7K | 15K |
| 2026-02-26 | Fisher Ryan C. | SVP, Gen. Counsel & Secretary | Grant | 192 | $0.00 | $0 | 15K |
| 2026-02-26 | Clontz Clarence Reid Jr. | SVP, Operations | Tax withholding | 69 | $70.52 | $5K | 7K |
| 2026-02-26 | Clontz Clarence Reid Jr. | SVP, Operations | Grant | 187 | $0.00 | $0 | 7K |
| 2026-01-02 | Segal Francis David | Director | Grant | 396 | $60.09 | $24K | 6K |
| 2026-01-02 | WILLIS J KEVIN | Director | Grant | 479 | $60.09 | $29K | 9K |
| 2025-10-02 | FERNANDEZ-MORENO LUIS M | Director | Tax withholding | 6K | $56.31 | $338K | 36K |
| 2025-10-01 | Segal Francis David | Director | Grant | 414 | $54.44 | $23K | 6K |
| 2025-10-01 | WILLIS J KEVIN | Director | Grant | 506 | $54.44 | $28K | 8K |
| 2025-08-11 | PLATT PHILLIP JOHN | SVP, Finance & CAO | Tax withholding | 1K | $52.20 | $75K | 28K |
| 2025-07-07 | Fisher Ryan C. | SVP, Gen. Counsel & Secretary | Tax withholding | 169 | $45.34 | $8K | 15K |
| 2025-07-01 | WILLIS J KEVIN | Director | Grant | 620 | $44.40 | $28K | 8K |
| 2025-07-01 | Segal Francis David | Director | Grant | 507 | $44.40 | $23K | 5K |
| 2025-05-01 | Segal Francis David | Director | Grant | 677 | $33.28 | $23K | 5K |
| 2025-05-01 | Segal Francis David | Director | Grant | 4K | $0.00 | $0 | 4K |
| 2025-05-01 | WILLIS J KEVIN | Director | Grant | 151 | $33.28 | $5K | 7K |
| 2025-05-01 | WILLIS J KEVIN | Director | Grant | 4K | $0.00 | $0 | 7K |
| 2025-05-01 | Hoechner Bruce D. | Director | Grant | 4K | $0.00 | $0 | 9K |
| 2025-05-01 | Wright Benjamin G. | Director | Grant | 4K | $0.00 | $0 | 10K |
| 2025-05-01 | NARWOLD KAREN G | Director | Grant | 4K | $0.00 | $0 | 17K |
| 2025-05-01 | Gulyas Diane H. | Director | Grant | 4K | $0.00 | $0 | 13K |
| 2025-05-01 | Sansone Daniel F | Director | Grant | 4K | $0.00 | $0 | 17K |
| 2025-05-01 | Lynch Frederick J | Director | Grant | 4K | $0.00 | $0 | 26K |
| 2025-05-01 | FERNANDEZ-MORENO LUIS M | Director | Grant | 4K | $0.00 | $0 | 53K |
| 2025-05-01 | Blackwell Jean | Director | Grant | 4K | $0.00 | $0 | 7K |
| 2025-04-07 | Li David H | President & CEO | Grant | 32K | $0.00 | $0 | 118K |
| 2025-04-07 | Li David H | President & CEO | Grant | 87K | $0.00 | $0 | 87K |
| 2025-04-01 | WILLIS J KEVIN | Director | Grant | 580 | $38.85 | $23K | 3K |
| 2025-03-25 | Fisher Ryan C. | SVP, Gen. Counsel & Secretary | Tax withholding | 310 | $43.07 | $13K | 15K |
| 2025-02-28 | Hulme Steven Paul | SVP and Pres, APT | Tax withholding | 278 | $47.66 | $13K | 3K |
| 2025-02-28 | Hulme Steven Paul | SVP and Pres, APT | Tax withholding | 152 | $47.66 | $7K | 4K |
| 2025-02-28 | Hulme Steven Paul | SVP and Pres, APT | Tax withholding | 94 | $47.66 | $4K | 4K |
| 2025-02-28 | Hulme Steven Paul | SVP and Pres, APT | Tax withholding | 104 | $47.66 | $5K | 3K |
| 2025-02-28 | PLATT PHILLIP JOHN | SVP, Finance & CAO | Tax withholding | 107 | $47.66 | $5K | 28K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON2 Form 144 notices on file for NGVT worth $1.8M at the prices reported; 2 in the last 90 days worth $1.8M. Latest: DAVID H LI filed on 2026-08-12 to sell 20,092 shares ($1.6M) from 2026-08-12.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-08-12 | DAVID H LIDirector, Officer | 20K | $1.6M | 0.058% | 2026-08-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-03 | RYAN C FISHEROfficer | 3K | $200K | 0.008% | 2026-08-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON2 holders report 5% or more of NGVT in their latest filing, all on Schedule 13G (passive). The largest reported stake is Vanguard Portfolio Management at 6.3% of the class (2,209,879 shares), filed 2026-04-29 for an event on 2026-03-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-05-15 | 13G/Ano. 1 | Wellington Investment Advisors Holdings LLPparent holding company | 1.5M | 4.2% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 1 | Wellington Group Holdings LLPparent holding company | 1.5M | 4.2% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 1 | Wellington Management Group LLPparent holding company | 1.5M | 4.2% | 2026-03-31 |
| 2026-04-30 | 13G | Vanguard Capital Managementinvestment adviser | 1.9M | 5.3% | 2026-03-31 |
| 2026-04-29 | 13G | Vanguard Portfolio Managementinvestment adviser | 2.2M | 6.3% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 13 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2025-10-24 | 13G/Ano. 1 | Victory Capital Management, Inc.investment adviser | 783K | 2.1% | 2025-09-30 |
13F holders
Tracked managers holding NGVT at their latest 13F. JSON7 of the 30 tracked managers held NGVT at their latest 13F, $85.8M in total at quarter-end prices. Millennium Management is the largest at $74.1M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 992K | $74.1M | 0.03% | -163K |
| Renaissance Technologies | 2026-06-30 | 63K | $4.7M | 0.01% | -59K |
| AQR Capital Management | 2026-06-30 | 35K | $2.6M | 0.00% | +4K |
| Bridgewater Associates | 2026-06-30 | 21K | $1.6M | 0.01% | +3K |
| Citadel Advisors | 2026-06-30 | 17K | $1.2M | 0.00% | +6K |
| Point72 Asset Management | 2026-06-30 | 15K | $1.1M | 0.00% | -53K |
| Two Sigma Investments | 2026-06-30 | 6K | $441K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Ingevity reported revenue of $314.1M, down 5.2% from the same quarter a year earlier, and net income of $35.3M (1.00 diluted EPS). In FY 2025 it generated $331.2M of operating cash flow and spent $56.3M on buybacks.
- Cash
- $97.4M
- Equity
- $46.9M
- Total assets
- $1.54B
- Shares outstanding
- 34,377,922
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $314.1M | $35.3M | 11.2% | 1.00 |
| Q1 FY 2026 | 2026-03-31 | $258.0M | $59.8M | 23.2% | 1.66 |
| Q4 FY 2025derived | 2025-12-31 | $255.1M | -$84.6M | -33.2% | n/a |
| Q3 FY 2025 | 2025-09-30 | $333.1M | $43.5M | 13.1% | 1.18 |
| Q2 FY 2025 | 2025-06-30 | $331.5M | -$146.5M | -44.2% | -4.02 |
| Q1 FY 2025 | 2025-03-31 | $247.9M | $20.5M | 8.3% | 0.56 |
| Q4 FY 2024derived | 2024-12-31 | $135.6M | $16.6M | 12.2% | n/a |
| Q3 FY 2024 | 2024-09-30 | $333.8M | -$107.2M | -32.1% | -2.94 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $1.17B | -$167.1M | $331.2M | n/a | $56.3M | n/a |
| FY 2024 | 2024-12-31 | $1.20B | -$430.3M | $128.6M | n/a | $0 | n/a |
| FY 2023 | 2023-12-31 | $1.22B | -$5.4M | $205.1M | n/a | $92.1M | n/a |
| FY 2022 | 2022-12-31 | $1.67B | $211.6M | $313.4M | n/a | $145.2M | n/a |
| FY 2021 | 2021-12-31 | $1.39B | $118.1M | $293.3M | n/a | $109.4M | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-24 from the cover page.
What this page is
Ingevity in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Ingevity (NGVT), SEC CIK 1653477, listed on NYSE, classified by the SEC as chemicals & allied products. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-23.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-23.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-08-12.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-05-15.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-07-29.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-01.JSON and CSV
- Company record
- EDGAR filing index for CIK 1653477Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as chemicals & allied products
Other company pages
Datasets
Frequently Asked Questions
How much of NGVT is sold short?
1,456,145 shares were held short at the 2026-09-30 settlement, 4.8 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is NGVT's daily short volume?
On 2026-10-23, 45,314 of the 77,966 NGVT shares reported to FINRA were sold short, 58.1% of the day's reported volume. Short volume is a flow for one day, not a position.
Does NGVT have fails to deliver?
The SEC's latest file shows 287 NGVT shares failed to deliver at settlement 2026-09-23. Fails are reported per settlement date and published twice a month with a lag.
Are NGVT insiders buying or selling?
Insiders at NGVT reported 7 open-market sells worth $1.7M in the last 90 days and no open-market buys. Latest filing: WILLIS J KEVIN (Director) on 2026-10-01.
Have NGVT insiders filed to sell?
2 Form 144 notices on file for NGVT worth $1.8M at the prices reported; 2 in the last 90 days worth $1.8M. Latest: DAVID H LI filed on 2026-08-12 to sell 20,092 shares ($1.6M) from 2026-08-12.
Who owns 5% or more of NGVT?
2 holders report 5% or more of NGVT in their latest filing, all on Schedule 13G (passive). The largest reported stake is Vanguard Portfolio Management at 6.3% of the class (2,209,879 shares), filed 2026-04-29 for an event on 2026-03-31.
What did NGVT report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) Ingevity reported revenue of $314.1M, down 5.2% from the same quarter a year earlier, and net income of $35.3M (1.00 diluted EPS). In FY 2025 it generated $331.2M of operating cash flow and spent $56.3M on buybacks.
Which tracked 13F managers own NGVT?
7 of the 30 tracked 13F managers held NGVT shares at their latest filing, $85.8M in all. The largest: Izzy Englander's Millennium Management (992K shares, $74.1M), Renaissance Technologies (63K shares, $4.7M), Cliff Asness's AQR Capital Management (35K shares, $2.6M), Ray Dalio's Bridgewater Associates (21K shares, $1.6M), Ken Griffin's Citadel Advisors (17K shares, $1.2M), Steve Cohen's Point72 Asset Management (15K shares, $1.1M). The table above lists all 7.
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.